High specific selectivity and Membrane-Active Mechanism of the synthetic centrosymmetric α-helical peptides with Gly-Gly pairs

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Jiajun ^a   Chou, Shuli ^a   Xu, Lin ^a   Zhu, Xin ^a   Dong, Na ^a   Shan, Anshan ^a   Chen, Zhihui ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; GLYCYL-GLYCYL-GLYCINE; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMICAL PHENOMENA; DRUG DESIGN; DRUG EFFECTS; DRUG POTENTIATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TEST; PROTEIN SECONDARY STRUCTURE; SYNTHESIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DRUG DESIGN; DRUG SYNERGISM; FLUORESCENCE RESONANCE ENERGY TRANSFER; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PROTEIN STRUCTURE, SECONDARY;

EID: 84946554877     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15963     Document Type: Article

References (60)

1. Onaizi, S. A. & Leong, S. S. Tethering antimicrobial peptides: current status and potential challenges. Biotechnology advances 29, 67-74, doi: 10.1016/j.biotechadv.2010.08.012 (2011).
2. Li, Y. M., Xiang, Q., Zhang, Q. H., Huang, Y. D. & Su, Z. J. Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application. Peptides 37, 207-215, doi: 10.1016/j.peptides.2012.07.001 (2012).
3. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389-395, doi: 10.1038/415389a (2002).
4. Auvynet, C. & Rosenstein, Y. Multifunctional host defense peptides: Antimicrobial peptides, the small yet big players in innate and adaptive immunity. Febs Journal 276, 6497-6508, doi: 10.1111/j.1742-4658.2009.07360.x (2009).
5. Giangaspero, A., Sandri, L. & Tossi, A. Amphipathic alpha helical antimicrobial peptides. European journal of biochemistry/FEBS 268, 5589-5600, doi: 10.1046/j.0014-2956.2001.02494.x (2001).
6. Yeaman, M. R. & Yount, N. Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27-55, doi: 10.1124/pr.55.1.2 (2003).
7. Dong, N. et al. Antimicrobial potency and selectivity of simplified symmetric-end peptides. Biomaterials 35, 8028-8039, doi: 10.1016/j.biomaterials.2014.06.005 (2014).
8. Liu, Y. F., Xia, X., Xu, L. & Wang, Y. Z. Design of hybrid beta-hairpin peptides with enhanced cell specificity and potent antiinflammatory activity. Biomaterials 34, 237-250, doi: 10.1016/j.biomaterials.2012.09.032 (2013).
9. Bell, G. & Gouyon, P. H. Arming the enemy: the evolution of resistance to self-proteins. Microbiology-Sgm 149, 1367-1375, doi: 10.1099/mic.0.26265-0 (2003).
10. Wiradharma, N. et al. Synthetic cationic amphiphilic alpha-helical peptides as antimicrobial agents. Biomaterials 32, 2204-2212, doi: 10.1016/j.biomaterials.2010.11.054 (2011).
11. Zelezetsky, I. & Tossi, A. Alpha-helical antimicrobial peptides - Using a sequence template to guide structure-activity relationship studies. Biochimica Et Biophysica Acta-Biomembranes 1758, 1436-1449, doi: 10.1016/j.bbamem.2006.03.021 (2006).
12. Tossi, A., Tarantino, C. & Romeo, D. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur J Biochem 250, 549-558, doi: 10.1111/j.1432-1033.1997.0549a.x (1997).
13. Yang, S. T., Shin, S. Y., Hahm, K. S. & Il Kim, J. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int. J. Antimicrob. Agents 27, 325-330, doi: 10.1016/j.ijantimicag.2005.11.014 (2006).
14. Yang, S. T., Shint, S. Y. & Kim, J. I. Interaction mode of a symmetric Trp-rich undeca peptide PST11-RK with lipid bilayers. Febs Letters 581, 157-163, doi: 10.1016/j.febslet.2006.12.003 (2007).
15. Lv, Y. F. et al. Antimicrobial Properties and Membrane-Active Mechanism of a Potential alpha-Helical Antimicrobial Derived from Cathelicidin PMAP-36. PLoS One 9, 12, doi: 10.1371/journal.pone.0086364 (2014).
16. Ma, Q. et al. Structure-Function Relationship of Val/Arg-rich Peptides: Effects of Net Charge and Pro on Activity. Chem. Biol. Drug Des. 84, 348-353, doi: 10.1111/cbdd.12325 (2014).
17. Zelezetsky, I., Pag, U., Sahl, H. G. & Tossi, A. Tuning the biological properties of amphipathic at-helical antimicrobial peptides: Rational use of minimal amino acid substitutions. Peptides 26, 2368-2376, doi: 10.1016/j.peptides.2005.05.002 (2005).
18. Liu, L., Fang, Y. & Wu, J. H. Flexibility is a mechanical determinant of antimicrobial activity for amphipathic cationic alphahelical antimicrobial peptides. Biochimica Et Biophysica Acta-Biomembranes 1828, 2479-2486, doi: 10.1016/j.bbamem.2013.06.017 (2013).
19. Senes, A., Gerstein, M. & Engelman, D. M. Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. J. Mol. Biol. 296, 921-936, doi: 10.1006/jmbi.1999.3488 (2000).
20. Chen, C. et al. Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptides. Biomaterials 33, 592-603, doi: 10.1016/j.biomaterials.2011.09.059 (2012).
21. Dong, N. et al. Strand Length-Dependent Antimicrobial Activity and Membrane-Active Mechanism of Arginine- and Valine-Rich beta-Hairpin-Like Antimicrobial Peptides. Antimicrob. Agents Chemother. 56, 2994-3003, doi: 10.1128/aac.06327-11 (2012).
22. Ma, Q. Q. et al. Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helixforming units. Amino Acids 43, 2527-2536, doi: 10.1007/s00726-012-1334-7 (2012).
23. Bär, W., Bäde-Schumann, U., Krebs, A. & Cromme, L. Rapid method for detection of minimal bactericidal concentration of antibiotics. Journal of microbiological methods 77, 85-89, doi: 10.1016/j.mimet.2009.01.010 (2009).
24. Zhu, X. et al. Design of imperfectly amphipathic alpha-helical antimicrobial peptides with enhanced cell selectivity. Acta Biomater. 10, 244-257, doi: 10.1016/j.actbio.2013.08.043 (2014).
25. Khara, J. S. et al. Anti-mycobacterial activities of synthetic cationic alpha-helical peptides and their synergism with rifampicin. Biomaterials 35, 2032-2038, doi: 10.1016/j.biomaterials.2013.11.035 (2014).
26. Thennarasu, S. et al. Antimicrobial and Membrane Disrupting Activities of a Peptide Derived from the Human Cathelicidin Antimicrobial Peptide LL37. Biophysical Journal 98, 248-257, doi: 10.1016/j.bpj.2009.09.060 (2010).
27. Bartlett, G. R. Phosphorus assay in column chromatography. The Journal of biological chemistry 234, 466-468 (1959).
28. Naarmann, N., Bilgiçer, B., Meng, H., Kumar, K. & Steinem, C. Fluorinated Interfaces Drive Self-Association of Transmembrane α Helices in Lipid Bilayers. Angewandte Chemie International Edition 45, 2588-2591, doi: 10.1002/anie.200503567 (2006).
29. Zhu, X. et al. Bactericidal efficiency and modes of action of the novel antimicrobial peptide T9W against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 59, 3008-3017, doi: 10.1128/aac.04830-14 (2015).
30. Park, K. H. et al. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. Biochimica Et Biophysica Acta-Biomembranes 1788, 1193-1203, doi: 10.1016/j.bbamem.2009.02.020 (2009).
31. Ulvatne, H., Samuelsen, O., Haukland, H. H., Kramer, M. & Vorland, L. H. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol. Lett. 237, 377-384, doi: 10.1016/j.femsle.2004.07.001 (2004).
32. Pauling, L. & Corey, R. B. Compound helical configurations of polypeptide chains: structure of proteins of the alpha-keratin type. Nature 171, 59-61, doi: 10.1038/171059a0 (1953).
33. Schiffer, M. & Edmundson, A. B. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophysical journal 7, 121-135, doi: 10.1016/s0006-3495(67)865792 (1967).
34. Sato, H. & Felix, J. B. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochimica Et Biophysica Acta-Biomembranes 1758, 1245-1256, doi: 10.1016/j.bbamem.2006.02.021 (2006).
35. Kim, H., Jang, J. H., Kim, S. C. & Cho, J. H. De novo generation of short antimicrobial peptides with enhanced stability and cell specificity. J. Antimicrob. Chemother. 69, 121-132, doi: 10.1093/jac/dkt322 (2014).
36. Dennison, S. R., Wallace, J., Harris, F. & Phoenix, D. A. Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships. Protein Pept. Lett. 12, 31-39, doi: 10.2174/0929866053406084 (2005).
37. Wang, G. S., Li, X. & Wang, Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 37, D933-D937, doi: 10.1093/nar/gkn823 (2009).
38. Chen, Y. X. et al. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 280, 12316-12329, doi: 10.1074/jbc.M413406200 (2005).
39. Saravanan, R. et al. Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility;. Biotechnol. Bioeng. 111, 37-49, doi: 10.1002/bit.25003 (2014).
40. Zhao, J., Zhao, C., Liang, G. Z., Zhang, M. Z. & Zheng, J. Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities. J. Chem Inf. Model. 53, 3280-3296, doi: 10.1021/ci400477e (2013).
41. Zhou, N. E., Kay, C. M. & Hodges, R. S. The Role of Interhelical Ionic Interactions in Controlling Protein Folding and Stability: De Novo Designed Synthetic Two-stranded α-Helical Coiled-Coils. J. Mol. Biol. 237, 500-512, doi: 10.1006/jmbi.1994.1250 (1994).
42. Wagschal, K., Tripet, B., Lavigne, P., Mant, C. & Hodges, R. S. The role of position a in determining the stability and oligomerization state of alpha-helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteins. Protein science: a publication of the Protein Society 8, 2312-2329, doi: 10.1110/ps.8.11.2312 (1999).
43. Wu, M., Maier, E., Benz, R. & Hancock, R. E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38, 7235-7242, doi: 10.1021/bi9826299 (1999).
44. Gopal, R., Seo, C. H., Song, P. I. & Park, Y. Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Amino Acids 44, 645-660, doi: 10.1007/s00726-012-1388-6 (2013).
45. Zelezetsky, I. et al. Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem. J. 390, 177-188, doi: 10.1042/bj20042138 (2005).
46. Liu, Z. G. et al. Length effects in antimicrobial peptides of the (RW)(n) series. Antimicrob. Agents Chemother. 51, 597-603, doi: 10.1128/aac.00828-06 (2007).
47. Yin, L. M., Edwards, M. A., Li, J., Yip, C. M. & Deber, C. M. Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J. Biol. Chem. 287, 7738-7745, doi: 10.1074/jbc.M111.303602 (2012).
48. Wen, S. Y., Majerowicz, M., Waring, A. & Bringezu, F. Dicynthaurin (ala) monomer interaction with phospholipid bilayers studied by fluorescence leakage and isothermal titration calorimetry. J. Phys. Chem. B 111, 6280-6287, doi: 10.1021/jp067794+ (2007).
49. Mattei, B., Miranda, A., Perez, K. R. & Riske, K. A. Structure-Activity Relationship of the Antimicrobial Peptide Gomesin: The Role of Peptide Hydrophobicity in Its Interaction with Model Membranes. Langmuir 30, 3513-3521, doi: 10.1021/la500146j (2014).
50. Arouri, A., Dathe, M. & Blume, A. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes. Biophys. Chem. 180, 10-21, doi: 10.1016/j.bpc.2013.05.003 (2013).
51. Zhu, X. et al. Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α -helical propensity. Acta Biomater. 18, 155-167, doi: 10.1016/j.actbio.2015.02.023 (2015).
52. Silverman, B. D. Hydrophobic moments of tertiary protein structures. Proteins: Structure, Function, and Bioinformatics 53, 880-888, doi: 10.1002/prot.10494 (2003).
53. Huang, J. F. et al. Inhibitory effects and mechanisms of physiological conditions on the activity of enantiomeric forms of an alpha-helical antibacterial peptide against bacteria. Peptides 32, 1488-1495, doi: 10.1016/j.peptides.2011.05.023 (2011).
54. Aquila, M., Benedusi, M., Koch, K. W., Dell'Orco, D. & Rispoli, G. Divalent cations modulate membrane binding and pore formation of a potent antibiotic peptide analog of alamethicin. Cell Calcium 53, 180-186, doi: 10.1016/j.ceca.2012.11.012 (2013).
55. Cirioni, O. et al. In vitro activities of tachyplesin III against Pseudomonas aeruginosa. Peptides 28, 747-751, doi: 10.1016/j. peptides.2007.01.001 (2007).
56. Huang, H. W. Action of antimicrobial peptides: two-state model. Biochemistry 39, 8347-8352, doi: 10.1021/bi000946l (2000).
57. Juretic, D., Vukicevic, D., Ilic, N., Antcheva, N. & Tossi, A. Computational Design of Highly Selective Antimicrobial Peptides. J. Chem Inf. Model. 49, 2873-2882, doi: 10.1021/ci900327a (2009).
58. Jiang, Z. Q. et al. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers 90, 369-383, doi: 10.1002/bip.20911 (2008).
59. Teixeira, V., Feio, M. J. & Bastos, M. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog. Lipid Res. 51, 149-177, doi: 10.1016/j.plipres.2011.12.005 (2012).
60. Lan, Y. et al. Structural contributions to the intracellular targeting strategies of antimicrobial peptides. Biochimica et Biophysica Acta (BBA)-Biomembranes 1798, 1934-1943, doi: 10.1016/j.bbamem.2010.07.003 (2010).